The Trump administration’s White House Fraud Task Force, led by Vice President JD Vance, has pursued dozens of criminal indictments since its establishment in February. However, healthcare leaders are urging caution in fraud enforcement, citing concerns about the moratorium on durable medical equipment.

Concerns About the Moratorium

Ryan Bullock, chief strategy officer at Aeroflow Health, expressed concerns about the moratorium, stating that it could have unintended consequences for legitimate providers. Aeroflow Health is a provider of durable medical equipment, including breast pumps, CPAP machines, and diabetes supplies.

Bullock emphasized the need for a more targeted approach to fraud prevention, rather than a broad brush approach. He suggested that the administration should focus on implementing better controls on the front end, such as vetting new suppliers, to prevent fraud.

Impact on Businesses

The moratorium has already had an impact on Aeroflow Health’s business, with a new location in Tampa, Florida, awaiting approval for a Medicare supplier number. Bullock noted that the company has passed multiple audits with Medicare and has proven to be a good steward of taxpayer dollars.

Bullock also called on the administration to update its random sampling period of Medicare recipients and to use artificial intelligence to identify abnormalities in data. He emphasized the need for transparency in the enforcement process, including sharing information on the success rate of fraud enforcement efforts.

Original reporting: KTBS 3 (Shreveport) — read the source article.